共 15 条
[3]
BYAR DP, 1979, CONTROVERSIES CANCER, P75
[4]
ELLENBERG SS, 1981, JAMA-J AM MED ASSOC, V246, P2481
[5]
GEHAN EA, 1981, SEMIN ONCOL, V8, P430
[6]
GREEN SB, 1981, CANCER-AM CANCER SOC, V47, P2671, DOI 10.1002/1097-0142(19810601)47:11<2671::AID-CNCR2820471125>3.0.CO
[7]
2-X
[8]
PATIENT HETEROGENEITY AND THE NEED FOR RANDOMIZED CLINICAL-TRIALS
[J].
CONTROLLED CLINICAL TRIALS,
1982, 3 (03)
:189-198
[9]
IMPROVED OBSERVATIONAL METHOD FOR STUDYING THERAPEUTIC EFFICACY - SUGGESTIVE EVIDENCE THAT LIDOCAINE PROPHYLAXIS PREVENTS DEATH IN ACUTE MYOCARDIAL-INFARCTION
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1981, 246 (21)
:2455-2459
[10]
THE APPLICATION OF THERAPEUTIC-TRIAL PRINCIPLES TO IMPROVE THE DESIGN OF EPIDEMIOLOGIC RESEARCH - A CASE-CONTROL STUDY SUGGESTING THAT ANTICOAGULANTS REDUCE MORTALITY IN PATIENTS WITH MYOCARDIAL-INFARCTION
[J].
JOURNAL OF CHRONIC DISEASES,
1981, 34 (12)
:575-583